Pangenomic health aktie forum. The Company's initial. Pangenomic health aktie forum

 
 The Company's initialPangenomic health aktie forum  @Fobibuddy The Company also announced that its board of directors has approved a reduction of the exercise price of an aggregate of outstanding 45,472,751 share purchase warrants of the Company (the “Warrants”) from $0

(“Generation IACP”) to. N-N6kQrkeXBQV39vtKCgMFC0uimY_VLCNyX7dlB17Y8. ("Mindleap") from Mydecine Innovations Group. CEOPanGenomic Health share price and NARA stock charts. 64% above the 52 week low of 0. 0. Pangenomic Health will provide further updates on its application to list on the AQSE when available. PanGenomic Health Admitted to Trading on the AQSE Growth Market in London,. +0,0001 EUR. com; Maryam Marissen, President & CEO, PanGenomic Health Inc. The Health Professions Review Board (HPRB) is an administrative tribunal created under the Health Professions Act (the Act). is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. Revenue in CAD (TTM) 0. PANGENOMIC HEALTH A AKTIE und aktueller Aktienkurs. PanGenomic Health Inc. 13 PANGENOMIC HEALTH INC REGISTERED SHS -A- Börsenplätze - hier finden Sie die aktuellen Preise der PANGENOMIC HEALTH INC REGISTERED SHS -A- Aktie an allen deutschen und ausländischen Börsenplätzen. . PanGenomic Health interim loss widens amid higher costs Aug. Today's RangePanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. The Company's initial focus is to support mental health. ("PanGenomic Health" or the "Company") (CSE: NARA) is pleased to announce that its subsidiary, PlantGx Diagnostics Corp. VANCOUVER, BC, Nov. ("PanGenomic Health" or the "Company") (CSE: NARA), is pleased to announce that, further to the announcement made on January 26, 2023, its subsidiary, MUJN Diagnostics Inc. The two companies are jointly developing targeted biomarker diagnostics to help patients undergoing. ("PanGenomic Health" or the "Company") (CSE: NARA), is pleased to announce its subsidiary, MUJN Diagnostics Inc. PanGenomic Health Inc. ISIN. Linked companies : Mydecine Innovations Group Inc. Pangenomic Health Inc. 778 743 4642 [email protected], BC, Aug. 15. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. Pangenomic Health Registered (A) Kurs heute • Aktuelle Realtime Finanzdaten, Nachrichten und Informationen zur Aktie • CA69842E2050 • DAX ±0,00 % MDAX ±0,00 %News zur PANGENOMIC HEALTH AKTIE und aktueller Realtime-Aktienkurs Pangenomic Health Inc: Pangenomic's MJUN rolls out BDNF health. ca - Mon Dec 12, 2022. Robert Nygren. Francisco Kent Carasquero. Nov. Nara is a mental health app that curates natural remedies for individuals to manage and improve their mental wellness. Its products include a mobile app for consumers (Nara), a telehealth mental health app and telehealth platform. nasdaq 100. has signed an letter of intent (LOI) for the sale of its digital technology subsidiary, Mindleap Health Inc. PanGenomic is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. Aktueller Aktienwert heute inkl. Vincent Lum CEO and Director at Pangenomic Health- Helping individuals take control of their health by providing personalized information (based on your needs, and biomarkes) on the use of plant. 0500. 616M. The NARA e-commerce platform offers curated information about natural supplements and lifestyle products, all tailored to. *Close price adjusted for splits. com. PanGenomic Health Inc. 28: CI Pangenomic Health Inc. VANCOUVER, BC, July 13, 2023 /CNW/ - PanGenomic Health Inc. Aktienverlauf & Wertentwicklung. meldet Ergebnis für das zweite Quartal und die sechs Monate bis zum 30. Stock analysis for PanGenomic Health Inc (LL30:Frankfurt) including stock price, stock chart, company news, key statistics, fundamentals and company profile. PanGenomic is also pleased to announce that the escrow release conditions for its recently completed financing of 7,365,999 subscription receipts (the "Subscription Receipts") at a price of $0. CSE: NARA, is pleased to announce, further to its news releases dated September 1, 2022 and November 21, 2022, the completion of its previously announced acquisition (the “Transaction”) of Mindleap Health Inc. . PanGenomic Health Inc. ("PanGenomic Health" or the "Company") (CSE: NARA) (AQSE: NARA), is pleased to announce that it has filed financial statements for the. We than track the effectiveness of the plant medicine by monitoring changes in a. Pangenomic Health Inc. care will market its. com (a global investor news source covering health and wellness stocks. The Company's initial focus is to support mental health. (“PanGenomic Health” or the “Company”) (CSE: NARA) (AQSE: NARA), is pleased to announce that it has entered into a non-binding letter of intent dated May 26, 2023 (“LOI”) with Interactive Health Inc. 13: Sales - Tangible Book Value 0. 30 per Class A Common Share of the Company (a “Share”) to $0. info@pangenomic. 2 Ratings. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ VANCOUVER, BC, Jan. Last Funding Type Post-IPO Equity. According to the National Institute of Mental Health Disorders, an estimated 26% of adults ages 18 and older suffer from a diagnosable mental disorder in a given year. 0 out of 5. ("PanGenomic Health" or the "Company") (CSE: NARA) (AQSE: NARA), is pleased to announce that its subsidiary, MUJN Diagnostics Inc. Automatisch Scrollen. At the core of our evidence-based health platform is an. (A) (spons. is a precision health company. The Company's initial focus is to support mental health. PanGenomic Health Inc. EVAHF. PressReader. 22, 2022 /CNW/ - PanGenomic Health Inc. VANCOUVER, BC, March 2, 2023 /CNW/ - PanGenomic Health Inc. Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social. Discover historical prices for NARA. Pangenomic Health Inc (LL30:MUN) set a new 52-week low during Thursday's trading session when it reached 0. F) stock discussion in Yahoo Finance's forum. It develops a self-care digital platform to deliver personalized, evidence-based information about natural treatments to support. Media. Data delayed at least 15 minutes, as of Nov 14 2023 07:01 GMT. PanGenomic Health Inc. The Company, through its subsidiaries, is engaged in developing a self-care digital platform to deliver personalized, evidence-based information about natural treatments. PANGENOMIC HEALTH A Fundamentalanalyse - hier erhalten Sie eine Analyse der PANGENOMIC HEALTH A Aktie nach fundamentalen Kennzahlen wie KGV, relative Performance, Mittelfrist-Trend usw. 0214, 6. 63 Followers. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. Pangenomic uses your genome/ proteomic profile to help users select the best plant medicine for their specific needs. DTCFF. PanGenomic Health is UK's first listed Public Benefit Corp after Aquis IPO. 0212 set on Aug 22, 2023. 9, 2023 /CNW/ - PanGenomic Health Inc. (Euro) Potential. PanGenomic acquired all of Mindleap's outstanding shares for a purchase price of C$3. 12, 2023 /CNW/ - PanGenomic Health Inc. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES /. 115946 million a year ago. com ‍ ‍ Bello Holdings Inc. The MUJN clinical decision support platform provides health practitioners with access to the consumer's mobile app data and their diagnostic reports. A3DN26. View funds that move the market, screen for funds and read relevant news. (dba Bello Capital Partners) 310 Water Street, Suite 306. 93. Registered as a British Columbia benefit company, PanGenomic Health's mission is to promote and improve. CA69842E2050. com Joined January 2021. S. com; Bello Holdings Inc. Pangenomic Health Inc. : Trading strategies, financial analysis, commentaries and investment guidance for Pangenomic Health Inc. Symbol: NARA. VANCOUVER, BC, May 30, 2023 /CNW/ - PanGenomic Health Inc. November 21, 2022 at 12:07 p. VANCOUVER, BC, Jan. Die DWS Group (DWS) ist einer der weltweit führenden Vermögensverwalter. Operating Status Active. Interaktiver realtime Chart zur PanGenomic Health Aktie. Nachrichten zur Aktie Defence Therapeutics Inc Registered Shs -A- Reg S. PanGenomic Health Inc. Pangenomic Health Inc (LL30:HAM) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more. The firm's products includ Nara App and PlantGx Platform. Investor Help Forum;06 Sep, 2022, 19:17 ET. Co-Founder ETC3 Emerging Technologies Centre May 2016 - Present 7 years 7 months. January 12, 2023. 2. Artikel lesen 02. Den Basisprospekt und die Endgültigen Bedingungen erhalten Sie hier, die Basisinformationsblätter hier. Popular. ("PanGenomic" or the "Company") (CSE: NARA) (AQSE:NARA) is pleased to announce that. euro stoxx 50. ftse-100Find the latest Pangenomic Health Inc. About PanGenomic Health Inc. Top Smart Score Stocks. announced that, further to the announcement made on January 26, 2023, its subsidiary, MUJN Diagnostics Inc. VANCOUVER, BC. is a precision health company. 31, 2023 /CNW/ - PanGenomic Health Inc. VANCOUVER, BC, Jan. CA2684692023. jC8D5hqezC0fLUBv3ZE7v7Lap_H_jhY--LqvHti_hEw. PanGenomic Health Inc - PanGenomic Health Subsidiary Announces First Sale of BDNF Biomarker Tests PR Newswire LONDON, United Kingdom, November 17 17 November 2023 PanGenomic ISIN CA69842E2050. 00; Net income in CAD-12. PanGenomic Health Announces Availability of Women's Hormonal Health DNA Report. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. PanGenomic. ROIC % explanation, calculation, historical data and morePangenomic Health Inc Aktie - Aktuelle Kurse und Unternehmensdaten. WKN. Pangenomic Health also announces that its Nara app now also. $512. Entwicklungen der Börsenkurse und Neuemissionen im Überblick. Pangenomic Health Inc Registered Shs -A- ist ein Unternehmen . com is for your general information and use. Börse. PanGenomic Health Inc. care. PanGenomic Health Inc. 15. President & CEO. Shares Outstanding 71. [email protected] Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. Its products include a mobile app for consumers (Nara), a telehealth mental health app and. Aktienverlauf & Wertentwicklung. The Company, through its subsidiaries, is engaged in developing a self-care digital platform to deliver personalized, evidence-based information about natural treatments. In December. Pangenomic Health A Realtimekurs. Find the latest Pangenomic Health Inc. company and executive profile by Barron's. 11. Name. The Company, through its subsidiaries, is engaged in developing a self-care digital platform to deliver personalized, evidence-based information about natural treatments. Registered as a British Columbia benefit company, PanGenomic Health's mission is to promote and improve. stock news by MarketWatch. . 20 per Unit, or such higher price as the Canadian Securities Exchange may require. +/-%. The Company's initial focus is to support mental health. ("PanGenomic Health" or the "Company") (CSE: NARA) is pleased to announce that Maryam Marissen has been. The company was founded by Robert Nygren and Vincent Lum on. See the latest PanGenomic Health Inc stock price (XCNQ:NARA), related news, valuation, dividends and more to help you make your investing decisions. ("PanGenomic" or the "Company") (CSE: NARA) is pleased to announce that it has initiated a non-brokered private placement financing of. 12 April 2022. PANGENOMIC HEALTH INC REGISTERED SHS -A- Börsenplätze - hier finden Sie die aktuellen Preise der PANGENOMIC HEALTH INC REGISTERED SHS -A- Aktie an allen deutschen und ausländischen Börsenplätzen. PANGENOMIC HEALTH A Rating: Hier finden Sie Rating-Informationen zu PANGENOMIC HEALTH A und Ratings der PANGENOMIC HEALTH A Anleihen sowie der Peer Group. PANGENOMIC HEALTH A Schätzungen: Hier finden Sie einen Überblick über die erwartete Entwicklung der wichtigsten Kennzahlen. Nachrichten zur Aktie HP Inc (ex Hewlett-Packard) | A142VP | HPQ | US40434L1052. Name. 38m; Incorporated 2015; Employees--Location Pangenomic Health Inc 102 3800 Wesbrook Mall VANCOUVER V6S 2L9 Canada CAN;. Forum; Kann das was ? Kann das was ?. To view PanGenomic Health’s complete subsidiaries history, request access ». ("PanGenomic" or the "Company") Pangenomic Health Inc. operates as a health care platform company. The Company's initial focus is to support mental health. com info@pangenomic. Over this period, the share price is down -91. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. 0191. View real. ("PanGenomic Health" or the "Company") (CSE: NARA), is pleased to announce that its Nara Plant Library is available now on the Nara app as a resource to provide science. , a company listed on the NEO Exchange, and Mydecine's wholly owned subsidiary, Mindleap Health Inc. Pangenomic Health-Aktie (NARA) Forum: Teilen Sie hier Ihre Meinungen und Trading-Ideen. is a public benefit company. Novum Securities Ltd. Under the terms of the agreement, Bello will provide a combination of capital. PanGenomic Health has raised a total of. is a precision health company. 11. (NARA) stock price, news, historical charts, analyst ratings and financial information from WSJ. Letzte Dividende. PanGenomic Health Provides Update for NARA Product and Conversational AI Canada NewsWire VANCOUVER, BC, June 6, 2023 VANCOUVER, BC, June 6, 2023 /CNW/ - PanGenomic Health Inc. VANCOUVER, BC, Nov. ("PanGenomic Health" or the "Company") (CSE: NARA) (AQSE: NARA), is pleased to provide an update on its NARA product and announce that it. PanGenomic Health Inc. 09 Nov, 2021, 17:34 ET. New look and feel! Ratings and Reviews 5. Artikel lesen 02. ISIN. ("PlantGx"), has signed a development partnership. ("PanGenomic Health" or the "Company") (CSE: NARA), is pleased to announce that its Nara Plant Library is available now on the Nara app as a resource to provide science-backed information about natural remedy alternatives to pharmaceutical drugs. -0,87%. (dba Bello Capital Partners), 310 Water Street, Suite 306, Vancouver, BC V6B1B6, 604 417 4440,. PanGenomic Health Inc. January 09, 2023 at 07:30 am. 23, 2023 /CNW/ - PanGenomic Health Inc. , 778 743 4642, info@pangenomic. PanGenomic is a health-tech company with an AI platform that supports consumer applications offering Telehealth, and diagnostic tools designed to improve quality and accessibility of care for. Earnings Trend: NARA is unprofitable, and losses have increased over the past 5 years at a rate of 77. VANCOUVER, BC, Jan. -4,11 %. Die kostenlose Realtimekurse-Push-Funktion steht börsentäglich zwischen 8 und 22 Uhr zur Verfügung. PanGenomic Health Inc. ("PanGenomic" or the "Company") (CSE: NARA), is pleased to announce that, further to its news release dated September 1, 2022, it has entered into a. Top Analyst Stocks. This news release includes certain statements that may be deemed “forward-looking statements”, including statements respecting the services to be provided by PanGenomic Health and the consideration to be paid to PanGenomic Health. 778 743 4642 778 743 4642. Loading more data. 74%. operates as a precision health company. AQ. Class A reported ― EPS in relation to -C$0. It develops a self-care digital platform to deliver personalized, evidence-based information about natural treatments to support. Nachrichten zur PANGENOMIC HEALTH A Aktie - Aktuelle TOP-Meldungen - Die wichtigsten PANGENOMIC HEALTH A News im Überblick - seriös, schnell und kompetent. **Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Apr. Nachrichten zur Aktie Pangenomic Health Inc Registered Shs -A- | A3DN26 |. Unternehmens-Meldungen im Überblick: Auf dieser Seite finden Sie alle Finanznachrichten zu Unternehmen in chronologischer Reihenfolge. 30, 2023 /CNW/ - PanGenomic Health Inc. VANCOUVER, BC, Dec. The LOI contemplates that the Pangenomic will acquire all of Mindleap's outstanding shares for a purchase price of. Nachrichten zur Aktie Microsoft Corp. ("PanGenomic" or the "Company") (CSE: NARA) is pleased to announce that Bello Capital Partners ("Bello") has been retained to provide capital markets advisory and digital. 0. 40. Weltweit vertrauen Kunden der DWS als Anbieter für integrierte Anlagelösungen. Letzter Kurs 08:56:21 Tradegate. operates as a precision health company. Catalog; For You; Stockwatch Daily. The Company’s. ("PanGenomic") (CSE: NARA) is pleased to announce that it has engaged Meus Management Inc. Kursentwicklung, News & Analysen. 778 743 4642 info@chatnels. CA69842E2050. PANGENOMIC HEALTH share price in real-time (A3DN26 / CA69842E2050), charts and analyses, news, key data, turnovers, company data. Aktie Pangenomic Health Inc. 1 Mindleap's aim is to. +/-%. Alle Nutzer können den Diskussionen auf Investing. 62%. Pangenomic Health is a digital health platform for plant medicine. ) Sartorius AG Vz. 12 April 2023 at 2:00 am · 8-min read. | PanGenomic Health’s mission is to improve the health and wellness of people by providing a technology platform that identifies plant-based solutions tailored to the health profile of each individual. Pangenomic Health Registered (A) ISIN: CA69842E2050 · WKN: A3DN26 · SYM: LL30 · Kanada. Er kritisiert die Aktie als klinisch tot und verwirft Vorwürfe gegen den CEO, der seine Scheine laufen lässt. High growth companies in the Healthcare. The Company, through its subsidiaries, is engaged in developing a self-care digital platform to deliver personalized, evidence-based information about natural treatments. PanGenomic Health Inc. 1 Year Return –84. ("PanGenomic Health" or the "Company") (CSE: NARA), is pleased to announce its intention to apply for admission. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. /CNW/ - PanGenomic Health Inc. HP AKTIE und aktueller Aktienkurs. EUR. -0,87%. Company Profile. Pangenomic Health Inc. . Our initial focus. . Ein Nutzer diskutiert die Aktie von Pangenomic Health Inc. 09:30:00 2023-10-31 am EDT 5-day change. CN) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives. The company was founded by Robert Nygren and Vincent Lum on December 11, 2015 and is headquartered in Vancouver, Canada. (“PanGenomic” or the “Company”) Admission to Trading on AQSE and First Day of Dealings. Push Kurse werden börsentäglich von 8:00 bis 23:00 Uhr, samstags von 10:00 bis 13:00 Uhr und sonntags von 17:00 bis 19:00 Uhr aktualisiert. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. kündigt Rücktritt von Direktoren an 13. . Dear Shareholders, As we. 1,08M. Latest Pangenomic Health Inc (LL30:FRA) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and. Perf. We have reserved some of the more detailed information for our. Übersicht Deine Holdings (0) Dividenden AnalysenFor several years, I’ve been working to change the world of healthcare by leveraging the power of tech, an effort that has landed me on the diverse and passionate team behind PanGenomic Health. PanGenomic Health Inc - PanGenomic Health Subsidiary Announces First Sale of BDNF Biomarker Tests PR Newswire LONDON, United Kingdom, November 17 17 November 2023 PanGenomic. 778 743 4642. PANGENOMIC HEALTH A Times and Sales - hier finden Sie eine Übersicht über die Käufe und Verkäufe (Umsätze) mit Uhrzeit und Volumen der PANGENOMIC HEALTH A Aktie an allen Börsenplätzen. euro stoxx 50. DEFENCE THERAPEUTICS A AKTIE und aktueller Aktienkurs. 107,68. . Likes. PanGenomic Health Inc. (“PanGenomic” or the “Company”) Admission to Trading on AQSE and First Day of Dealings. 04/05/2023 08:04:49 Cookie Policy +44 (0) 203 8794 460. PanGenomic Health Inc. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. by Globe Newswire January 30, 2023. All markets data located on FT. Earnings Per Share-0. , is pleased to announce the filing of its business acquisition report relating to its acquisition of all outstanding shares of Mindleap. Finanzsoftware die Spaß macht - kostenlos und werbefrei. ("Hemex Health"), a Portland, Oregon-based medical diagnostic device company focused on developing life. Le 15 juillet/July 2022. 778 743 4642 info@chatnels. ("PanGenomic Health" or the "Company") (CSE: NARA), is pleased to. 9, 2023 /CNW/ - PanGenomic Health Inc. 31, 2023 /CNW/ - PanGenomic Health Inc. Portfolio Tracking Watchlists Märkte Dividendenkalender Neu Community Blog Registrieren Anmelden Aktie. (formerly named PlantGx Diagnostics Corp. : Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Deutsche Boerse AG. PanGenomic is committed to helping more people discover plant-based health remedies and giving them greater personal control over. Registered as a British Columbia benefit company, Pangenomic Health's mission is to promote and improve the health. Healthcare Software Software. com. Pangenomic Health Inc. The Company's initial. 2023 – 00:50. WKN A3DN26 | ISIN CA69842E2050 | PANGENOMIC HEALTH Aktie mit aktuellem Realtime Kurs, Chart, Nachrichten, Fundamentaldaten, Analysen, Meinungen & Empfehlungen. The PanGenomic personalized health platform helps consumers and healthcare practitioners connect with precision plant-based mental health treatments. It develops the Nara App, a mental health app that curates natural remedies for individuals to manage and improve mental wellness; Mindleap, a mental health tracker that offers access to audio content, blogs, and professional services for mental well-being; and MUJN that offers. Pangenomic Health competitive advantages and company strategy can generally be found in its financial reports archived here. Alle Nutzer können den Diskussionen auf Investing. VANCOUVER, BC, Jan. Earnings vs Industry: NARA is unprofitable, making it difficult to compare its past year. stock was issued. PanGenomic Health Inc is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments to support mental health. ("PanGenomic" or the "Company") (CSE: NARA), is pleased to announce that, further to its news release dated September 1, 2022, it has. Aktueller Aktienwert heute inkl. PanGenomic Health Completes Acquisition of Mindleap Health. (PAN) auf einem Forum, das sich mit der Entwicklung von Impfstoffen und Therapien für Krebs befasst. Er übernimmt die ETF-Auswahl, ist steuersmart. The Company's initial. The Company's initial. . (MT Newswires) -- PanGenomic Health (NARA. euro stoxx 50. Registered as a British Columbia benefit company, PanGenomic Health's mission is to promote and improve. (CNSX:NARA) signed an arm's length non binding Letter of Intent to acquire Mindleap Health Inc. PanGenomic Health Inc. | CA69842E2050. Get the latest Pangenomic Health Inc (NARA) real-time quote, historical performance, charts, and other financial information to help you make more informed. CN stock on Yahoo Finance. Find the latest Pangenomic Health Inc. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. Letzter Kurs 02. PANGENOMIC HEALTH A Rating: Hier finden Sie Rating-Informationen zu PANGENOMIC HEALTH A und Ratings der PANGENOMIC HEALTH A Anleihen sowie. View real. PanGenomic is a healthtech company on a mission to offer effective and accessible tools that transform the status quo in the world of mental and physical health. Official Data Partner. Redcare Pharmacy Kurs heute • Aktuelle Realtime Finanzdaten, Nachrichten und Informationen zur Aktie (RDC) • NL0012044747 (A2AR94) • Handel • VersandhandelBMW AKTIE und aktueller Aktienkurs. PanGenomic Health Inc. PanGenomic Health is a. Tweets. PANGENOMIC HEALTH A Rating: Hier finden Sie Rating-Informationen zu PANGENOMIC HEALTH A und Ratings der PANGENOMIC HEALTH A Anleihen sowie der Peer Group. [email protected] Jones 30 Industrial, NASDAQ Composite Index, S&P 500, NASDAQ 100, S&P 100, BX Swiss - USA. (LL30. Artikel lesen 02. 07. , a Santa Clara-based medical device company ("LumiQuick "). EUR. )("MUJN Diagnostics"), has signed an agreement to lease space at Psy Integrated. PanGenomic Health’s Nara Plant Library is Now Available. 30: AN Pangenomic Health Inc. CN) with historical highs & lows, new high & low prices, past performance, latest news.